GLP-1 Drug Dulaglutide Protects Kidneys in High Blood Pressure Model | Research

The takeaway

Dulaglutide protected against hypertension-induced kidney damage in rats by activating PPAR-gamma and restoring VEGF signaling.

6-week kidney protection
Dulaglutide improved renal function markers and reduced inflammation in hypertensive rats

What the researchers found

Dulaglutide (0.2 mg/kg/day) for six weeks ameliorated L-NAME-induced hypertensive kidney damage through PPAR-gamma activation and VEGF restoration, improving renal function and reducing inflammation.

Why it matters

Kidney protection is a critical unmet need in hypertension management. If GLP-1 drugs can directly protect kidneys, they could be valuable additions to treatment for hypertensive patients.

How the study worked

Animal study (rats) with L-NAME-induced hypertension treated with dulaglutide for 6 weeks, measuring renal function biomarkers, cytokines, redox status, and PPAR-gamma/VEGF expression.

What this study cannot tell us

Animal study — rat models of hypertension may not fully translate to human hypertensive nephropathy. Single dose level tested.

How to read the evidence

Preclinical animal study — demonstrates mechanism of renal protection but requires human validation.

When this study was published

Published in 2026; contributes to the growing evidence of GLP-1 RA organ-protective effects.

The bigger picture

This adds to evidence that GLP-1 receptor agonists have organ-protective effects beyond metabolic control, potentially benefiting the cardiovascular-renal axis.

Questions still open

Would dulaglutide protect human kidneys in hypertensive patients without diabetes?
How do these renoprotective effects compare to established kidney-protective drugs like ACE inhibitors?

Common questions

Can GLP-1 drugs protect kidneys?

This animal study shows dulaglutide can protect kidneys from high blood pressure damage through anti-inflammatory mechanisms. Human studies are needed to confirm these kidney-protective effects.

What is hypertensive nephropathy?

Hypertensive nephropathy is kidney damage caused by chronic high blood pressure. It is the second most common cause of end-stage kidney disease, affecting millions worldwide.

Read the original research

Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF.

Hypertension research : official journal of the Japanese Society of Hypertension, 49(3), 816-828

View on PubMed ↗Publisher’s paper ↗

Citation

Bastawy, Nermeen; El-Mosallamy, Aliaa E M K; Rasheed, Rabab Ahmed; Sadek, A S; Khattab, R T; Ali, Esraa; Zaghloul, Randa A; Ghaly, Wael B A; Boushra, Amy F. (2026). Renoprotective effect of dulaglutide in L-NAME-induced hypertensive nephropathy in rats: insight into the roles of PPAR-gamma and VEGF.. Hypertension research : official journal of the Japanese Society of Hypertension, 49(3), 816-828. https://doi.org/10.1038/s41440-025-02403-9